Abstract. Cerebral palsy is a common birth disorder that frequently involves ischemic-type injury to developing white matter (WM). Dead glial cells are a common feature of this injury and here we describe a novel form of acute ischemic cell death in developing WM astrocytes. Ischemia, modeled by the withdrawal of oxygen and glucose, evoked [Ca 2ϩ ] i increases and cell death in astrocytes in post-natal day 10 (P10) rat optic nerve (RON). Removing extracellular Ca 2ϩ prevented increases in [Ca 2ϩ ] i but increased the amount of cell death. Astrocytes showed rapid [Na ϩ ] i increases during ischemia and cell death was reduced to control levels by substitution of extracellular Na ϩ or Cl Ϫ or by perfusion with bumetanide, a selective Na-KCl cotransport (NKCC) blocker. Astrocytes showed marked swelling during ischemia in the absence of extracellular Ca 2ϩ , which was blocked by bumetanide. Raising the extracellular osmolarity to limit water uptake reduced ischemic astrocyte death to control levels. Ultrastructural examination showed that post-ischemic astrocytes had lost their processes and frequently were necrotic, effects partially prevented by bumetanide. At this point in development, therefore, NKCC activation in astrocytes during ischemia produces an osmo-regulatory challenge. Astrocytes can subsequently regulate their cell volume in a Ca 2ϩ -dependent fashion but this will require ATP hydrolysis and does not protect the cells against acute cell death.
INTRODUCTION
Ischemic injury of white matter (WM) is an important element of a variety of pathological conditions ranging from stroke to developmental brain disorders. For example, cerebral palsy is a common human birth disorder most frequently characterized by ischemic-type WM lesions that arise in mid-gestation as myelination is getting underway (1) . While the mechanisms underlying ischemic injury of developing oligodendroglial cells have been examined (2, 3) , nothing is currently known about astrocyte injury at this age. In severe clinical cases, the acute phase of injury involves cell death of both oligodendroglia and astrocytes in addition to damage to axons (4) . While a loss of oligodendroglia in surviving patients has suggested a focus upon this glial cell type, the central role that astrocytes play to support neural development and function indicate that astrocyte injury may influence the extent of functional loss (5) . Furthermore, since oligodendroglial injury may be dependent upon an increase in extracellular glutamate (2, 3, 7) , the response of astrocytes during injury may determine the fate of oligodendrocytes. For example, astrocytes are an important site of glutamate uptake in the CNS under normal conditions and are a potential source of glutamate release during ischemia (6, 7) .
No attempt has previously been made to examine the mechanism of ischemic-type injury during myelin initiation using a preparation where cells exist in an approximately normal extracellular environment. The major difficulty with a study of this kind is the presence of multiple cell types in situ, which makes the identification of a single cell type difficult. In the current study, the technique of rapid live staining is used to examine ion fluxes and acute cell death in identified glia. This approach is justified by a series of control experiments and allows closely opposed cells within a mixed cell population to be studied in situ. The ionic-dependence and pharmacology of injury in identified astrocytes have been examined, revealing a unique form of astrocyte injury that involves Na-K-Cl cotransport (NKCC) activation, osmotic stress, and loss of cell processes. The consequences of this injury pathway for oligodendroglial injury during ischemia are examined in a companion paper (7) .
MATERIALS AND METHODS
Post-natal day 8 (P8) to P12 (referred to as ''P10'' throughout) Long-Evans rats of both sexes were narcotized by exposure to 20% O 2 /80% CO 2 prior to decapitation. Both optic nerves were dissected free and removed from their outer connective tissue layer. Local ethical committee approval was obtained for all experiments (University of Washington and Leicester University).
ISCHEMIC INJURY OF ASTROCYTES
J Neuropathol Exp Neurol, Vol 63, of 7.45). The osmolarity of the PBS was measured and adjusted to 330 mOsm by addition of NaCl. RAN-2 primary antibody (8) , produced as a mouse hybridoma cell supernatant (cells from ATCC, Manassas, VA; with the assistance of Dr. K. Neugebauer, University of Washington), was used at a ratio of 1:3. Rabbit anti-platelet derived growth factor alpha receptor (PDGF␣R) (9) (Upstate Biotechnology, Lake Placid, NY) was used at 1:1,000. A primary antibody was added to the PBS and incubated for 30 min. All staining incubations were performed at 37ЊC (rather than the 4ЊC normally employed in live staining) in a dark, humidified chamber maintained in 5% CO 2 /95% O 2 . The appropriate secondary antibody (used 1:1,000) was then added to the primary antibody/PBS solution and incubated for a further 25 min. Cy3 conjugated goat anti-rabbit or goat antimouse IgG (whole molecule adsorbed for cross species reactivity) was used (Jackson ImmunoResearch, West Grove, PA). To maximize these protocols for speed, blocking steps and prolonged washing steps were omitted. Following the immunostaining, RONs were thoroughly washed in PBS prior to gradual replacement with artificial cerebrospinal fluid (aCSF), normal composition (in mM): NaCl, 126; KCl, 3; NaH 2 PO 4 , 1.25; MgSO 4 , 2; CaCl 2 , 2; NaHCO 3 , 26; glucose, 10; pH, 7.45, bubbled with 5% CO 2 /95% O 2 . The osmolarity of aCSF was measured and adjusted to 330 mOsm by addition of NaCl if required. Fluorescent dye loading was performed in 1 ml aCSF. RONs were incubated for 50 min in the presence of either 10 M SBFI-AM (sodium-binding benzofuran; Molecular Probes, Eugene, OR) or 7.5 M FURA-2-AM (Molecular Probes). RONs were washed in aCSF prior to mounting for cell imaging. In cell imaging experiments of live-stained cells, the focal plane was manually adjusted at the start of the experiment to allow the experimenter to confirm that antibody staining correlated with a specific dye-loaded cell.
Background secondary antibody staining (no prior exposure to primary antibody) was of lower intensity when performed in PBS (zero Ca 2ϩ ) than when performed in aCSF (2 mM Ca 2ϩ ). However, staining intensity was not reduced further by addition of either 50 M or 5 mM EGTA. Blocking with normal serum (Jackson ImmunoResearch), at either 1% or 5% for 60 min did not eliminate the residual non-specific staining. The degree of low-intensity staining was somewhat dependent upon the choice of the secondary antibody. Trials with a number of antibodies from different sources and derived from various species, identified goat whole molecule antibodies adsorbed for cross-species reactivity (rat, mouse, and human) as providing the lowest level of low-intensity staining.
The NKCC-1 isoform was detected in RON of various ages using the T4 monoclonal antibody (1:100) (10; Departmental Studies Hybridoma Bank, Iowa City, IA) detected with an FITC conjugated secondary antibody (Jackson ImmunoResearch).
Deconvolution Microscopy
Live cell immunohistochemistry and fluorescent-dye-loaded cell identification were investigated with deconvolution microscopy. RONs were placed on a coverslip in a drop of PBS and installed on the stage of an inverted fluorescence microscope (Nikon Eclipse TE 200; Nikon USA, Melville, NY). The perimeter of the nerve (to a depth of approximately 50 m) was visualized using DIC optics with oil-immersion, long-working distance ϫ20 or ϫ40 objectives (CFI Planapochromat, Nikon). DIC and fluorescent images were collected using a SENSYS CCD camera using METAMORPH software (Universal Imaging Corp, Downingtown, PA). Images were recorded over a Zrange using a motorized stage-stepper (LUDL, Hawthorne, NY) controlled via METAMORPH. Steps of ϳ250 nm for ϫ20 and ϳ150 nm for ϫ40 were chosen, using a formula provided by the manufacturer, and produced deconvolved images that were adequate for this study. Typically, 40 to 80 images were recorded per stack. Separate image stacks were recorded for each fluorophore using appropriate filter sets. Image stacks were exported to a Silicon Graphics O 2 (SGI, Mountain View, CA), workstation running SoftWoRx software (Applied Precision, Issaquah, WA). Constrained iterative deconvolution was performed on the image stacks using a point spread function calculated for the appropriate optics. Final image stacks were overlaid using SoftWoRx. The process of deconvolution acts to reduce background signal in a 3-dimensional image stack. In no case did the procedure generate signals that were not apparent in the original images. The final images are not equivalent to 2-dimensional sections such as produced by cryo-sectioning or confocal microscopy, but produced adequate images of stained glial cells in live whole mount RON.
Cell Imaging
Dye-loaded RONs were transferred to a glass coverslip and fixed at either end with a small amount of cyanoacrylate glue (11) . The coverslip was then sealed onto the base of an atmosphere chamber (Warner Instruments, Hamden, CT) using vacuum grease and placed on the stage of a Nikon Diaphot-TMD inverted epi-fluorescent microscope. aCSF was run through the chamber at a rate of 1 to 2 ml/min and removed via a vacuum line. The chamber was heated to 37ЊC via independent feedback-controlled stage, objective, and tubing heaters (Bioptechs and Warner Instruments). The atmosphere in the chamber was initially maintained as 5% CO 2 /95% O 2 and cells imaged as described previously (11) . Cell death was assessed as the point when FURA-2 was released from the cell in a step-wise fashion such that 360-nm intensity fell to the background level. This event occurred simultaneously with collapse of cell membrane integrity and has been used as an indicator of cell death in a number of prior studies (11) (12) (13) , and could be elicited in the current preparation by exposing the RONs to a detergent (Triton X-100). Ischemic conditions were created by switching to an aCSF with 0 mM glucose that had been bubbled for a minimum of 60 min with 5%CO 2 /95% N 2 at 37ЊC. The atmosphere in the recording chamber was simultaneously switched from 5% CO 2 / 95% O 2 to 5%CO 2 /95% N 2 . Ischemic conditions were initiated after a 5-min period of control recording and were maintained for a standard 40-min period (except the data where a 55-min ischemic period was used). Glia in the RON are maintained in a normal extracellular space that responds in the appropriate fashion to ischemic conditions in terms of changes in ionic composition (11) , and therefore it was not necessary to modify the ionic composition of the ''ischemic'' solution. Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO choline chloride (n ϭ 55) or NMDG (n ϭ 26), with no significant difference between the 2 sets of data. Isethionate was substituted for Cl Ϫ in Cl Ϫ -replacement aCSF (which produced a 12.5% drop in free aCSF [Ca 2ϩ ] as a result of chelation, determined using free FURA-2). Calibration solutions for SBFI experiments contained 1 mM ouabain, 3 M gramicidin, and 10 M monensin, and were buffered with HEPES (14) . Statistical significance was calculated via ANOVA or t-test with Bonferroni post-test as appropriate using a significance level of p Ͻ 0.01 (Graphpad, Prism Software, San Diego, CA). Each experimental condition was performed on a minimum of 6 RONs.
Volume Changes
Volume changes were assessed in RAN-2ϩ cells loaded with calcein-AM (2 M in aCSF ϩ0.1% DMSO) for 50 min at room temperature (RT) (15, 16) . After transfer to the recording chamber, an ROI was drawn around a sub-cellular region of each calcein-loaded RAN-2ϩ cell and changes in cell water content were subsequently assessed as changes in calcein fluorescent intensity (excited at 490 nm and viewed between 510 and 540 nm). Drift of the fluorescence signal resulting from dye leakage and photo bleaching was corrected using the standard protocol of calculating the rate constant of decline during an initial 5-min period of baseline recording and subtraction from subsequent measurements (17, 18) . While small changes in calcein fluorescence can be detected due to dye quenching when large numbers of whole cells are assayed using fluorescence correlation spectroscopy (16), the current protocol of assessing dye concentration changes in sub-regions of individual cells produces data that correlates inversely with cell volume changes (18) .
Dye Fixation
Fluorescent dye was fixed in situ using the cross-linking agent 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (11, 19) . RONs were washed in PBS and exposed to fresh EDC (30 mg/ml) for 60 min at RT. The RONs were then washed for 10 min in PBS ϩ 0.1 M glycine to extinguish any remaining cross-linking activity before further washing in PBS. Typically, RONs live stained with RAN-2 were fixed for co-labeling with intracellular epitopes such as GFAP. In these cases, RONs were fixed before transferal to PBS containing 0.1% Triton X-100 for 40 min at RT. RONs were then washed prior to incubation in PBS, 1% normal serum, and primary antibody overnight at 4ЊC. RONs were subsequently washed in PBS for 60 min prior to incubation in secondary antibody for 2 hours in PBS. RONs were washed a final time prior to installation in the deconvolution microscope.
Electron Microscopy
To allow direct comparison of results, RONs prepared for EM were first exposed to the normal incubation and perfusion periods used for cell imaging (including actual cell imaging for 60 min). RONs were then washed in Sorenson's buffer prior to post-fixation in 3% glutaraldehyde/Sorenson's for 90 min at RT before washing and storage at 5ЊC. The RONs were post-fixed with 2% osmium tetroxide and dehydrated in ethanol and propylene oxide. The nerves were then infiltrated in epoxy resin and the ends cut back prior to taking ultrathin sections. Sections were counterstained with uranyl acetate and lead citrate and examined with a JEOL 100CX electron microscope (Peabody, MA). To avoid bias in the data, electron micrographs were collected blind (by R. F.) to the experimental procedure used to produce each sample.
RESULTS

Live Staining
FURA-2 loaded into a large population of glial cells in P10 RON (Fig. 1B) . AM-dye-loading protocols typically produce dye loading in only a proportion of cells within a CNS whole-mount or brain slice preparation (11, 20) . The dye loading protocol used here will produce FURA-2 loading of a mixed population of oligodendroglia and astrocytes. In order to distinguish these cell types once they have been dye loaded, RONs were subject to a rapid live-staining protocol. Typical live staining with RAN-2 antibody (which is selective for astrocytes) of the same RON section is shown in Figure 1A (overlaid in Fig. 1C , violet indicates co-localization), demonstrating the presence of some RAN-2ϩ cells that were also FURA-2-loaded. In addition, there were numerous FURA-2-loaded cells that were not stained with RAN-2. The mean proportion of FURA-2-loaded cells that were RAN-2ϩ was 44.8 Ϯ 4.4% (n ϭ 3 RONs). RAN-2 staining was found largely around the perimeter of cells, as shown by examination of images collected at different focal depths. Rapid live staining produced a significant amount of non-specific labeling in the form of primary antibody-independent staining. Such non-specific labeling was consistently of a lower intensity level than the primary antibody-dependent staining (approximately one order of magnitude lower in terms of absolute intensity). For comparison purposes, control data is shown in Figure  1D -F. In this P10 RON, normal staining and dye loading procedures were followed with the exception that the primary antibody was omitted. Figure 1D shows secondary antibody staining under these conditions using the same recording parameters, image gain, and threshold as that used in Figure 1A . The companion FURA-2 image is shown in Figure 1E and the overlay in Figure 1F . Nonspecific staining was evident but did not compare in intensity to that found in RAN-2-treated RONs. For comparison purposes, for use in later studies (9) and as a form of control for the present study, oligodendroglial cell staining with PDGF␣R was examined. In the P10 RON, oligodendroglial cells are present mainly in the form of precursor cells and pre-oligodendrocytes (21, 22) , which selectively express the PDGF␣R (22) (23) (24) . Live PDGF␣R staining of P10 RON produced a proportion of anti-PDGF␣R-labeled cells that were FURA-2-loaded (not shown). Control experiments where the primary antibody was omitted were performed, which showed a low level of primary antibody-independent staining of a similar degree to that seen in RAN-2 control experiments. RAN-2 and anti-PDGF␣R co-labeling of P10 RON is shown in Figure 1G and 1I. The RON was first labeled with RAN-2 using the normal live-staining protocol followed by washing with PBS, blocking for 60 min with 4% BSA, and a second staining protocol for (bar), ischemia (shaded area) had little effect upon the 340/380 ratio but produced cell death (arrow). Note: the 340/380 ratio does not reflect cell changes once cell death has occurred and intracellular FURA-2 has been released. B: In the presence of the NKCC blocker bumetanide (50 M; bar), ischemia evoked an increase in the 340/380 ratio and cell death did not occur. C: In Cl Ϫ -substituted aCSF (bar), ischemia evoked a large increase in the 340/380 ratio but no cell death. D: In Na ϩ -substituted aCSF (bar), ischemia evoked a large increase in the 340/380 ratio but no cell death. E: The change in the over all degree of cell death during a 40-min period of ischemia compared to separate control (no ischemia) experiments. Note that conditions that inhibit NKCC, such as Na ϩ substitution, Cl Ϫ substitution, or perfusion with bumetanide, reduced cell death to control levels. Neither removing extracellular Ca 2ϩ nor perfusion with DIDS was protective. *Asterisk indicates significantly different degree of cell death during ischemia; ''n'' indicates the total number of RAN-2ϩ cells. The 340/380 ratio and 360 intensity plot for a representative RAN-2ϩ cell simultaneously exposed to ischemia and high osmolarity (50 mM sucrose). Ischemia evoked an increase in the 340/380 ratio that was not associated with cell death. B: In this RAN-2ϩ cell exposed to high osmolarity under normoxic conditions, the 340/ 380 ratio was stable and the cell died after 28 min (arrow). PDGF␣R. RAN-2 and PDGF␣R-stained images are overlaid in Figure 1I , demonstrating 2 non-overlapping populations of cells. These images were collected as an image stack and the 1 cell that appears in this plane to express both markers was in fact 2 cells located close together in the z-axis.
The identity of live RAN-2-stained P10 RON cells was investigated using immunohistochemistry. RONs were live stained with RAN-2 prior to staining for GFAP (Fig.  1J-L) or vimentin (not shown). All RAN-2-stained cells were GFAPϩ, with RAN-2 restricted to cell bodies and GFAP located in both somata and processes. 49.2% of GFAP-stained cells was RAN-2ϩ (assayed in one RON), suggesting that RAN-2ϩ cells form a sub-set of RON astrocytes. Vimentin labeling was relatively sparse and a small number of RAN-2ϩ cells were vimentinϩ.
While non-specific staining was effectively not visible in normal gain images (Fig. 1M) , high gain images showed the presence of low-intensity staining that had a clear cellular origin (Fig. 1N) . A large number of such cells can be seen in a sibling RON exposed to the secondary antibody in the absence of the primary antibody (Fig. 1P) , although once again these are not apparent at normal gain (Fig. 1O) . The arrows in Figure 1N and 1P indicate cells that are visible at high gain but not visible at normal gain.
To ensure that exposure to antibody did not affect the tendency of cells to die during a period of ischemia, cell death data was collated for all FURA-2-loaded cells (not just stained cells) in the series of RAN-2 (n ϭ 228), PDGF␣R (n ϭ 349), and no primary antibody control experiments (n ϭ 266). Cell death was determined by the sudden loss of 360 fluorescence from a cell to back ground levels. The total percentage of cells that died during a 55-min period of ischemia in the 3 classes of RON was not significantly different (37.5 Ϯ 8.1%, 38.5 Ϯ 7.7%, and 38.2 Ϯ 7.9%, respectively). The profile of when cell death tended to occur during a 55-min period of ischemia was also similar between the 3 groups of cells (data not shown).
Live Stained Cell Imaging
The imaging set-up collected single-plane images that were not as clear as the deconvolved images seen in the previous section. However, distinct cellular antibody staining was evident with some of the FURA-2-loaded cells being antibody-positive ( Fig. 2A, B) . With the less sensitive image collection system used for imaging no significant, low-intensity, primary antibody-independent staining was detected in control (i.e. no primary antibody) experiments. Data were collected from 489 FURA-2-loaded cells in 16 RAN-2-stained RONs. 127 (26% of total) of the FURA-2-loaded cells were RANϩ, in comparison, 16% of FURA-2-loaded cells were PDGF␣Rϩ. In control experiments, 11 Ϯ 7.1% of RAN-2ϩ cells died during 45 min of perfusion with aCSF (n ϭ 46), while 21.8 Ϯ 6.3% of RAN-2ϩ cells died during the standard 45-min period of recording (5 min of control ϩ 40 min of ischemia). The changes in the 340/380 ratio (correlating with changes in [Ca 2ϩ ] I : (25) produced by ischemia in a representative set of identified RAN-2ϩ cells is shown in Figure 2C . Cells that died are indicated by a thicker line that terminates prior to the end of the recording period. The majority of RAN-2ϩ cells experienced significant increases in the 340/380 ratio during ischemia, although a number of cells showed either a very small increase or a decline.
There was no significant relationship between the 340/ 380 ratio change at the time of cell death compared to the time to cell death during ischemia. However, there was a correlation between the rate at which the 340/380 The 340/380 ratio and 360 intensity changes in representative astrocytes at 4 age points. Ischemia is indicated by the gray areas and cell death by arrows. At each age, cell death is preceded by an increase in the 340/380 ratio. E-H: Histograms showing the incidence of cell death at the four age points. I: Extent of astrocyte death during the standard 40-min ischemia protocol at various ages. Cell death determined by FURA-2 dye loss at all ages. Astrocytes were identified as such by rapid live RAN-2 staining at all time points except P2, when it has previously been shown that FURA-2-loaded cells are all astrocytes. J-L: NKCC expression at P2, P5, and P10, respectively. Note that expression is not detected at P2 but robust expression is found by P5. M: NKCC expression (green) has a cellular form and did not overlap with PDGF␣R straining (red) in this P10 RON. N: NKCC (green) expression coincides with RAN-2 staining (red).
ratio changed prior to death and time to cell death. The change in the 340/380 ratio that occurred in a cell prior to cell death (relative to the ratio at the start of the recording period) was divided by the time to cell death and is plotted against time to cell death in Figure 2D . It is apparent that RANϩ cells that exhibited large and rapid increases in the 340/380 ratio died earlier than those that showed smaller, slower increases. A time histogram of cell death during ischemia shows increasing levels of cell death as the period of ischemia increases (Fig. 2E) . 
Ca 2ϩ -Dependence of Ischemic Cell Death
In the absence of extracellular Ca 2ϩ , ischemia evoked no significant changes in the 340/380 ratio in RAN-2ϩ cells (n ϭ 58; Fig. 3A) . The degree of cell death was significantly higher in the absence of Ca 2ϩ (32.8 Ϯ 4.5%, n ϭ 58; p Ͻ 0.001), while RAN-2ϩ cell death in control experiments where RONs were exposed to 45 min of perfusion with zero-Ca 2Ϫ aCSF (10 Ϯ 0.5%, n ϭ 50) was similar to normal aCSF controls. There was no significant relationship between rate of 340/380 increase and time to cell death in the absence of Ca 2ϩ (Fig. 3B) , and cell death tended to occur early during the period of ischemia in the absence of extracellular Ca 2ϩ (Fig. 2C, histogram, left  scale) . The cumulative rate of cell death was plotted as a line for both the normal aCSF and zero-Ca 2ϩ experiments (right scale). This showed that in the absence of Ca 2ϩ , RAN-2ϩ cell death is apparent earlier than in normal aCSF.
The Role of NKCC
While a proportion of RAN-2 ϩ cells that died during ischemia did not show significant elevation in 340/380 ratio, many RAN-2ϩ cells that survived ischemia displayed large ratio increases (Fig. 2C) . A typical RAN-2ϩ cell that died during ischemia in the absence of Ca 2ϩ is shown in Figure 4A , demonstrating an essentially flat 340/380 ratio prior to death. Since Ca 2ϩ did not appear to mediate acute death of RAN-2ϩ cells, other ionic mechanisms were examined. Astrocytes are known to swell under ischemic conditions (26) (27) (28) , and astrocyte swelling is mediated in large part by NKCC (29, 30) . Conditions that inhibit NKCC activity were found to block acute ischemic death of RAN-2 ϩ cells (Fig. 4) . Perfusion with the selective NKCC blocker bumetanide, substitution of most of the extracellular Na ϩ , or substitution of extracellular Cl Ϫ were all highly protective of RAN-2ϩ cells (Fig. 4B-E) . Under these conditions cells typically showed large increases in the 340/380 ratio even though they survived ischemia (Fig. 3B-E) . The less specific Cl Ϫ channel blocker DIDS, which does not affect the NKCC, failed to provide protection from injury (Fig.  4E) .
NKCC activation is associated with Na ϩ influx. The Na ϩ -sensitive dye SBFI was used to assess [Na ϩ ] i changes in RAN-2ϩ cells. The Na ϩ -dependent 345/385 ratio in SBFI-loaded cells was stable under control conditions but increased rapidly following the onset of ischemia (Fig.  5A, B) . The 345/385 ratio remained high during the period of ischemia and, in cells that survived the period of recording, the ratio responded in the appropriate manner to calibration solutions (Fig. 5B). [Na ϩ ] i recordings were made from a total of 54 RAN-2ϩ cells, 19 of which were calibrated. The 345/385 ratio increased by 22.4 Ϯ 0.55% during ischemia (n ϭ 54), while ratio was stable during prolonged perfusion with aCSF (Fig. 5C) . In RAN-2ϩ cells that died during SBFI-imaging (evident as the collapse of 345 Na ϩ -insensitive intensity), a sharp peak in the 345/385 ratio was observed prior to cell death (Fig.  5A ).
Cell Swelling
Forces acting to cause cell swelling can be countered by elevating the extracellular osmolarity (31) . Raising the extracellular osmolarity by 50 mOsm (aCSF ϩ 50 mM sucrose) reduced the degree of acute ischemic cell death to 15 Ϯ 4.3% (n ϭ 52; p Ͻ 0.001) compared to cell death than under normal ischemic conditions. Surviving cells typically showed a significant elevation in the 340/380 ratio during ischemia (Fig. 6A) . However, control experiments revealed that perfusion with 50 mM sucrose in otherwise normal aCSF for 40 min produced a significant amount of cell death (52 Ϯ 5.4%, n ϭ 42). This cell death was not associated with changes in the 340/380 ratio (Fig.  6B ). This cell death was not investigated further, and indicates that WM astrocytes at this point in development are highly sensitive to volume changes.
Cell volume changes were directly assessed using a calcein dilution protocol (15, 16) . During perfusion with aCSF, RAN-2ϩ cells showed a gradual increase in calcein fluorescence, indicating gradual cell shrinkage (Fig. 7A ). Exposure to ischemia had no significant effect upon cell volume (Fig. 7B ), but significant swelling was observed during ischemia in the absence of extracellular Ca 2ϩ (Fig.  7C) . Ischemia therefore produced a significant tendency for astrocytes to swell, which the astrocytes regulate via a previously described form of Ca 2ϩ -dependent regulatory volume decrease (32) . The Ca 2ϩ -dependent swelling produced by ischemia was completely abolished by bumetanide, showing that the tendency to swell is mediated by NKCC (Fig. 7D, E) .
Developmental Changes in NKCC Expression and Cell Death
Acute ischemic injury of astrocytes in P0-P2 RON is Ca 2ϩ -mediated and independent of extracellular Na ϩ (11), which is fundamentally different from the injury characterized here 8 days later in development. Representative 340/380 ratio changes in FURA-2-loaded astrocytes, recorded in RONs at various ages, are shown in Figure  8A -D. In each case the 340/380 ratio increased during ischemia prior to cell death. The incidence of acute cell death is shown in histograms (Fig. 8E-H) , showing that while astrocyte death tended to occur during the early part of ischemia at P2, cell death tended to increase progressively with time in P10 and adult. The proportion of astrocytes that die during 40 min of ischemia increases significantly from P2 to P5 as the underlying mechanism of injury is changing (Fig. 8I) .
NKCC expression was absent in P2 RON, with robust cellular expression at P5 and P10 (Fig. 8J-L) . A similar time-course for NKCC expression has been previously reported in rat CNS (33, 34) . Co-labeling with cell-specific markers revealed that NKCC expression was limited to RAN-2ϩ cells in P10 RON and was absent from PDGF␣Rϩ cells (Fig. 8M, N) . Control experiments where the primary antibody was omitted showed no detectable staining and cross-reactivity and/or bleedthrough was not seen. Oligodendroglial NKCC expression has previously been shown to be restricted to myelinating cells, which are rare at P10 and will be PDGF␣R-(33), while robust expression has been found in rat astrocytes, including RON astrocytes (34, 35) . The expression of NKCC in astrocytes as they mature therefore confers a new pathway to cell injury that has significant consequences for their chances of surviving ischemia.
Ultrastructural Changes
The ultrastructure of the RON at this age has been characterized previously (21) . Astrocytes can be identified on the basis of key morphological features. On the perimeter of the RON, astrocytes extend processes that form an ensheathing layer called the glial limitans (Fig.  9A) . Other processes extend and ramify through the RON, some of which contain intermediate filaments (Fig.  9, insert, white arrow) . The cytoplasm of astrocytes is dark, contains a characteristic wide-bore endoplasmic reticulum (Fig. 9, arrows) and has few mitochondria. The nucleus has a characteristic lobular shape with chromatin typically clustered under the envelope. Astrocytes such as this may be very closely apposed to larger cells with clear cytoplasm containing many mitochondria (Fig. 9) . These are oligodendroglial cells and have processes that can occasionally be traced out to compact myelin that ensheaths axons (21) . Surrounding the glial cell somata are numerous non-somatal regions made up largely of axons with axoplasm containing prominent microtubules, astrocyte processes characterized by a dark cytoplasm that can on occasion be traced back to astrocyte somata, and extracellular space. Away from the perimeter of the RON, similar cell types can be identified (Fig. 9, bottom) . Astrocytes typically have multiple highly elaborate and extensive processes and oligodendroglia sometimes have either a homogeneous chromatin (Fig. 9) or a more lobular form, typical of dividing cells. At this age it is known that astrocytes are post-mitotic, while some oligodendroglia are actively multiplying (36) .
Astrocyte somata and the non-somatal regions were severely disrupted in post-ischemic RON (Fig. 10) . Astrocytes could be clearly identified in post-ischemic RON on the basis of their dark cytoplasm containing an endoplasmic reticulum (ER) that had become distended and, in some cases, by the remnants of glial-limitans forming processes (Fig. 10, top) . In all cases, astrocyte processes had broken apart and detached from the somata (Fig. 10 , bottom) in a process described by Alzheimer in the ischemic brain as ''clasmatodendrosis'' (37) . Dead cells (cells with no competent cell membrane) with the features of astrocytes were common (Fig. 10, top) . In surviving cells, mitochondria were always swollen (Fig. 10,  bottom) .
The changes that typify astrocytes in post-ischemic RON were largely unseen in RONs made ischemic in the absence of Na ϩ and Ca 2ϩ . The exception was astrocyte mitochondria swelling, which was common under these conditions (Fig. 11, top) . Mitochondrial swelling in astrocytes was evident even though ER morphology appeared normal (Fig. 11, top) . Mitochondria in oligodendroglia had a normal appearance in RONs made ischemic in the absence of Na ϩ and Ca 2ϩ (Fig. 11, top) . Astrocytes made ischemic in the presence of bumetanide retained far more elaborate processes than astrocytes made ischemic in the absence of bumetanide and fewer dead astrocytes were observed (Fig. 11, bottom) . Changes in organelles were not abolished by bumetanide, in particular mitochondrial swelling and a limited degree of ER swelling were observed (Fig. 11, bottom) . to begin the process of ensheathment. This period is characterized by a heightened sensitivity to ischemic injury (3, (38) (39) (40) (41) . This increased ischemic sensitivity may result from vascular, metabolic, or cellular factors (2-4, 38, 42) . Immature WM is apparently subject to ischemia during the development of the lesion, periventricular leukomalacia (PVL). PVL is the major pathology associated with cerebral palsy (4, 42, 43) , a birth disorder affecting ϳ2/ 3 per 1,000 live births in the West (44) . Histological studies report the earliest cellular manifestation of severe PVL is a coagulating necrosis involving glial cells and axons in certain developing WM structures.
Patients surviving PVL exhibit paucity of myelin in the affected region (45, 46) . This has led to the hypothesis that oligodendroglial injury may occur differentially and may be central to the subsequent loss of function (40, 41, 43) . However, coagulating necrosis clearly involves injury and death of both oligodendroglia and astroglia (4), indicating that both cell types are sensitive to the acute phase of ischemia. Considering that astrocytes are essential partners for normal brain development (5) , and astrocyte injury may be central for subsequent oligodendrocyte injury (7), astrocyte injury will be an important determining factor in the extent of functional loss. The current study shows that the mechanisms of acute astrocyte injury during ischemia at this point in development are very different from those operating in the period immediately prior to myelin initiation (11). The cellular mechanisms described here are amenable to pharmacological intervention using clinically proven drugs that may therefore be useful in cases when the fetus is at risk of ischemic brain damage.
Live Staining
Astrocyte precursor cells appear in the RON around embryonic day 13 (E13) and astrocytes around E18 (21, 36) . By P10 most astroglia are in the astrocyte form. RAN-2 is the only selective surface marker currently identified for astrocytes (7) . All RAN-2ϩ cells identified using the current rapid live-staining protocol were GFAPϩ, while only a proportion of GFAPϩ cells were RAN-2ϩ. A number of studies report that GFAP is itself present in a sub-population of astrocytes in a number of brain regions (47) . Whether this will limit the relevance of the current finding to a sub-set of RAN-2ϩ astrocytes is unclear. NKCC expression was detected only in RAN-2ϩ cells in the P10 RON in the current experiments, but NKCC expression is known to be widely expressed in neurons and glia in the CNS at various points in development (33) (34) (35) . Given the importance of astrocytes in extracellular homeostasis during ischemia, the injury described here may have significant consequences for other cell types during ischemia, even if restricted to a subpopulation of astrocytes.
The rapid live staining/cell imaging protocols described here allowed intracellular ionic changes and the time-course of acute cell death to be assessed simultaneously in identified astrocytes and oligodendroglia in situ. The protocol resulted in a significant amount of primary antibody-independent staining of cellular origin, which prior reports suggest may be microglia or ''myelinforming'' cells (48) , and could be reliably distinguished from RAN-2ϩ cells on the basis of labeling intensity. The problem of cell identification for in situ studies could have been solved using fluorescent protein expression linked to cell specific promoters (49) . However, this approach lacks the flexibility of rapid live staining, where secondary antibody selection can be matched to the spectral properties of specific ion-sensitive dyes, and epitope selection can be easily altered. Furthermore, the current approach employs rats, making the results directly applicable to the many previous studies in ischemia research that have used this animal.
Mechanisms of Acute Ischemic Injury in Developing WM Astrocytes
The data suggest that developing WM astrocytes die during ischemic conditions as a result of NKCC activation, Na ϩ and Cl Ϫ influx and the consequent tendency to swell. A similar form of acute cell death has been reported in neuronal cultures (31) , which was potentiated by removing extracellular Ca 2ϩ in a similar fashion to the astrocyte injury documented here. Developing WM astrocyte death is therefore a consequence of an ongoing osmo-regulatory challenge during ischemia that requires the cells to volume-regulate using a previously described Ca 2ϩ -dependent mechanism (32) . Astrocyte volume regulation requires ATP hydrolysis (51) , presumably leading to a rapid depletion of energy reserves and subsequent cell lysis.
At an earlier stage in development (P0-P2), acute ischemic injury of RON astrocytes is mediated by Ca 2ϩ influx (11), a different mechanism of injury to that found at P10. The extent of cell death is greater at P10, paralleling the appearance of NKCC (Fig. 8) and the downregulation of voltage-gated Ca 2ϩ channels (52) . Such a significant change in the ionic basis of acute ischemic cell death in cells that are 8 days or less apart in development may be part of the explanation of why WM is so sensitive to ischemic injury during the early stages of myelination. In the current study, astrocytes that exhibit a rapid elevation in the 340/380 ratio tended to die quickly during ischemia, even though Ca 2ϩ did not mediate acute cell death. The conditions that produce Ca 2ϩ influx will also strongly activate the NKCC. The stoichiometry of NKCC is thought to be Na:1/K:1/Cl:2; resulting in electro-neutral transport (53) . The transporter is activated by high extracellular K ϩ (53, 54), which will also activate various pathways to Ca 2ϩ -influx such as Na-Ca exchange and voltage-gated Ca 2ϩ channels. The significance of this study lies in the novelty of the mechanism underlying early astrocyte injury in developing WM. However, as with neuronal injury during stroke (55) , it would appear that this pathway is not the only harmful event occurring during ischemia in developing WM astrocytes. Thus, even when the acute phase of injury described here was prevented by removing Na ϩ and Ca 2ϩ or perfusing with bumetanide, it is clear that pathological changes occurred in cells that may well result in cell death at later time points ( Fig. 11; ref. 15 ). Since prolonged elevation in [Ca 2ϩ ] i is harmful to most cells, it is also likely that the NKCC-mediated injury described here will operate in parallel with a slower Ca 2ϩ -dependent form of cell injury. Presumably Ca 2ϩ -mediated injury would be apparent during longer periods of ischemia.
The astrocyte injury produced by acute ischemia described here involves clasmatodendrosis and cell lysis. The disruption of astrocyte processes and loss of cell membrane integrity produced by acute ischemia will result in the spilling of intracellular glutamate into the extracellular space. Ischemic conditions in general may promote glutamate release from astrocytes as a result of reversal of glutamate uptake and opening of swellingactivated glutamate permeable channels (6, 56) . Since the mechanism of oligodendroglial injury may involve glutamate receptor activation (2, 3, 9) , these events are likely to have important consequences for oligodendroglial survival during ischemia and the whole sequence of harmful events that follow the onset of ischemia in the developing human brain. Considering the widespread expression of NKCC in the mature CNS, the mechanisms described here may also be applicable to ischemic injury in the developed CNS, for example during stroke.
